LTS - Lohmann Therapy Systems
David Picciano is a seasoned professional in regulatory and compliance management, currently serving as Sr. Manager in DEA/Regulatory Affairs at LTS - Lohmann Therapy Systems since May 2020. Additionally, David is the Owner and Founder of Now That’s Disney, a platform for Disney enthusiasts. David’s expertise in DEA compliance has been honed through various roles, including DEA Compliance Manager at Aurobindo Pharma USA, Inc., and QA Manager for DEA Compliance at Ohm Laboratories, Inc. Educational qualifications include a Certificate in Computer Technical Support from Chubb Institute and a diploma from Roselle Park High School. David's extensive experience spans over two decades in the pharmaceutical sector, focusing on controlled substance regulations and compliance.
This person is not in any offices
LTS - Lohmann Therapy Systems
LTS Corp is the US-based subsidiary of Lohmann Therapie Systeme whose headquarters are in Andernach, Germany. LTS’s research and development focuses on two new technologies to complement and expand the potential of alternative drug delivery systems. In addition to the development of LTS Transdermal and LTS Oral Thin Film technologies, the company also develops innovative microneedle and the ‘active LTS Transdermal’ technology. LTS Microneedles that are long enough to penetrate the outer layer of skin but too short to irritate nerves and blood vessels. They can be used to inject active substances with larger molecules into the skin, an application that is largely pain-free. Microneedles create tiny holes in the outermost layer of skin, which significantly increases the rate at which the active substance is absorbed. LTS is currently researching a number of different microneedles made from different materials and with different gauges, designs and sizes for a wide range of applications.